Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study

Study Questions:

What is the risk and time frame of bleeding associated with dual antiplatelet therapy after myocardial infarction (MI) or percutaneous coronary intervention (PCI) on top of vitamin K antagonist (VKA) therapy for atrial fibrillation (AF) patients?